These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 19642176)

  • 1. Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis.
    Gratwohl A; Stern M; Brand R; Apperley J; Baldomero H; de Witte T; Dini G; Rocha V; Passweg J; Sureda A; Tichelli A; Niederwieser D;
    Cancer; 2009 Oct; 115(20):4715-26. PubMed ID: 19642176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Gratwohl A; Brand R; Apperley J; Crawley C; Ruutu T; Corradini P; Carreras E; Devergie A; Guglielmi C; Kolb HJ; Niederwieser D;
    Haematologica; 2006 Apr; 91(4):513-21. PubMed ID: 16533723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the EBMT risk score in chronic myeloid leukemia in Brazil and allogeneic transplant outcome.
    De Souza CA; Vigorito AC; Ruiz MA; Nucci M; Dulley FL; Funcke V; Tabak D; Azevedo AM; Byington R; Macedo MC; Saboya R; Penteado Aranha FJ; Oliveira GB; Zulli R; Martins Miranda EC; Azevedo WM; Lodi FM; Voltarelli JC; Simões BP; Colturato V; De Souza MP; Silla L; Bittencourt H; Piron-Ruiz L; Maiolino A; Gratwohl A; Pasquini R
    Haematologica; 2005 Feb; 90(2):232-7. PubMed ID: 15710577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction of the oncological pediatric risk of mortality score (O-PRISM) for ICU support following stem cell transplantation in children.
    Schneider DT; Lemburg P; Sprock I; Heying R; Göbel U; Nürnberger W
    Bone Marrow Transplant; 2000 May; 25(10):1079-86. PubMed ID: 10828869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.
    Tichelli A; Passweg J; Wójcik D; Rovó A; Harousseau JL; Masszi T; Zander A; Békássy A; Crawley C; Arat M; Sica S; Lutz P; Socié G;
    Haematologica; 2008 Aug; 93(8):1203-10. PubMed ID: 18556401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation and extension of the EBMT Risk Score for patients with chronic myeloid leukaemia (CML) receiving allogeneic haematopoietic stem cell transplants.
    Passweg JR; Walker I; Sobocinski KA; Klein JP; Horowitz MM; Giralt SA;
    Br J Haematol; 2004 Jun; 125(5):613-20. PubMed ID: 15147377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hematopoietic cell transplantation-specific comorbidity index fails to predict outcomes in high-risk AML patients undergoing allogeneic transplantation--investigation of potential limitations of the index.
    Birninger N; Bornhäuser M; Schaich M; Ehninger G; Schetelig J
    Biol Blood Marrow Transplant; 2011 Dec; 17(12):1822-32. PubMed ID: 21708108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential prognostic impact of pretransplant comorbidity on transplant outcomes by disease status and time from transplant: a single Japanese transplant centre study.
    Kataoka K; Nannya Y; Ueda K; Kumano K; Takahashi T; Kurokawa M
    Bone Marrow Transplant; 2010 Mar; 45(3):513-20. PubMed ID: 19684632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation.
    Abboud I; Porcher R; Robin M; de Latour RP; Glotz D; Socié G; Peraldi MN
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1251-7. PubMed ID: 19747632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk-adjusted outcome measurement in pediatric allogeneic stem cell transplantation.
    Matthes-Martin S; Pötschger U; Bergmann K; Frommlet F; Brannath W; Bauer P; Klingebiel T
    Biol Blood Marrow Transplant; 2008 Mar; 14(3):335-43. PubMed ID: 18275900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of readmission in children receiving allogeneic hematopoietic stem cell transplantation: an institutional experience.
    Jaing TH; Tsay PK; Yang CP; Hung IJ; Wen YC; Tseng CK
    Transplant Proc; 2008 Dec; 40(10):3643-5. PubMed ID: 19100457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive fungal infections in allogeneic and autologous stem cell transplant recipients: a single-center study of 166 transplanted patients.
    Post MJ; Lass-Floerl C; Gastl G; Nachbaur D
    Transpl Infect Dis; 2007 Sep; 9(3):189-95. PubMed ID: 17511828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second solid cancers after allogeneic hematopoietic stem cell transplantation.
    Gallagher G; Forrest DL
    Cancer; 2007 Jan; 109(1):84-92. PubMed ID: 17131350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of HLA-E*0103 homozygosity on survival after allogeneic hematopoietic stem-cell transplantation.
    Danzer M; Polin H; Pröll J; Haunschmid R; Hofer K; Stabentheiner S; Hackl C; Kasparu H; König J; Hauser H; Binder M; Weiss R; Gabriel C; Krieger O
    Transplantation; 2009 Aug; 88(4):528-32. PubMed ID: 19696636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic hematopoietic SCT for patients with autoimmune diseases.
    Daikeler T; Hügle T; Farge D; Andolina M; Gualandi F; Baldomero H; Bocelli-Tyndall C; Brune M; Dalle JH; Urban C; Ehninger G; Gibson B; Linder B; Lioure B; Marmont A; Matthes-Martin S; Nachbaur D; Schuetz P; Tyndall A; van Laar JM; Veys P; Saccardi R; Gratwohl A;
    Bone Marrow Transplant; 2009 Jul; 44(1):27-33. PubMed ID: 19139739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous hematopoietic stem cell transplantation as an intensive consolidation therapy for adult patients in remission from acute myelogenous leukemia.
    Jung AS; Holman PR; Castro JE; Carrier EK; Bashey A; Lane TA; Nelson CL; Pu M; Messer K; Corringham SM; Ball ED
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1306-13. PubMed ID: 19747639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality.
    Poutsiaka DD; Price LL; Ucuzian A; Chan GW; Miller KB; Snydman DR
    Bone Marrow Transplant; 2007 Jul; 40(1):63-70. PubMed ID: 17468772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis in transplant-eligible patients with agnogenic myeloid metaplasia: a simple CBC-based scoring system.
    Dingli D; Schwager SM; Mesa RA; Li CY; Tefferi A
    Cancer; 2006 Feb; 106(3):623-30. PubMed ID: 16369987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric standard-risk AML with fully matched sibling donors: to transplant in first CR or not?
    Gassas A; Afzal S; Ishaqi MK; Finkelstein-Shechter T; Rojas M; Dupuis A; Sung L; Doyle J
    Bone Marrow Transplant; 2008 Sep; 42(6):393-6. PubMed ID: 18587434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partially matched related donor transplantation can achieve outcomes comparable with unrelated donor transplantation for patients with hematologic malignancies.
    Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Yu W; Huan C; Yu-Hong C; Wei H; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Feng-Rong W; Fei-Fei T
    Clin Cancer Res; 2009 Jul; 15(14):4777-83. PubMed ID: 19584148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.